Infection Mortality in AIDS: Immunologic Mechanisms & Opportunistic Pathogens
AIDS (CD4 <200 cells/µL or AIDS-defining illness) creates profound immunodeficiency, transforming normally harmless organisms into lethal pathogens.
Immunologic Basis of Vulnerability
- CD4+ T-cell depletion: Loss of Th1 (IFN-γ, macrophage activation), Th17 (mucosal defense), Tfh (B-cell help), Treg (immune regulation)
- Impaired cell-mediated immunity: Intracellular pathogen control fails (TB, fungi, viruses, parasites)
- Humoral dysfunction: B-cell hyperactivation but poor specific antibody response; polyclonal hypergammaglobulinemia
- Innate immune defects: Neutrophil oxidative burst, macrophage phagocytosis, NK cell function impaired
- High viral load: HIV viremia → immune activation, exhaustion, apoptosis
Major Opportunistic Infections (OIs) by CD4 Stratum
| CD4 Count | Typical OIs |
|---|---|
| >500 | TB, bacterial pneumonia, HSV, VZV (shingles) |
| 200–500 | Oral/esophageal candidiasis, HPV, Kaposi sarcoma |
| <200 | PCP (Pneumocystis jirovecii), Toxoplasma encephalitis, Cryptococcal meningitis |
| <100 | MAC (M. avium complex), CMV retinitis/colitis, Progressive multifocal leukoencephalopathy (JCV) |
| <50 | Disseminated fungal (Histoplasma, Coccidioides), CNS lymphoma, severe wasting |
Synergistic Mortality Factors
- Coinfections: TB + HIV → 2× mortality; HCV → accelerated liver disease
- Malnutrition/wasting: Catabolic state → immune collapse
- Immune reconstitution inflammatory syndrome (IRIS): Paradoxical worsening on ART
- Diagnostic delays: Atypical presentations, limited resources
- Treatment access: Drug interactions (rifampin + PIs/NNRTIs), toxicity, adherence
Prevention Strategy (WHO/CDC)
- ART initiation ASAP: Restores CD4, reduces OI risk 70–90%
- Primary prophylaxis: TMP-SMX (PCP, toxo), azithromycin (MAC), fluconazole (crypto) per CD4 thresholds
- Vaccination: Pneumococcal, HepB, HPV, COVID, flu (inactivated); avoid live if CD4<200
- Screening: TB (IGRA), crypto Ag (if CD4<100), CMV viremia
Modern ART transforms AIDS from fatal to chronic manageable condition. Early diagnosis and sustained viral suppression prevent OIs.
HIV & AIDS - Related Articles
- HIV Prevention: Proven Strategies to Reduce Transmission Risk
- Understanding HIV Treatment Effectiveness: Why Results May Vary
- HIV/AIDS & Cognitive Function: Debunking the "Brain Shrinkage" Myth
- Understanding HIV/AIDS: How the Virus Impacts the Human Body
- Circumcision and HIV Risk: Protective Effect
- HIV Origins: Natural Evolution from Primates, Not Lab Creation
- Condom Effectiveness: Limitations and Proper Use Tips
